Almadex Announces Plans to Drill at Paradise, Acquires Royalty at Willow, and Provides Corporate Update on Mexico

In This Article:

Almadex Minerals Ltd.
Almadex Minerals Ltd.

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- Almadex Minerals Ltd. ("Almadex" or the "Company") (TSX-V: “DEX”) is pleased to announce its plan to commence a drill program of approximately 2,000 metres to test lithocap targets recently defined at the Paradise project in Nevada, USA.

As described in its news release of February 27th, 2024, Almadex defined a porphyry copper-gold target at Paradise through mapping and soil geochemistry. Further detailed mapping was recently completed on the porphyry target area at the project. This work defined two separate zones of porphyry lithocap alteration:

  1. A diaspore-pyrophyllite-dickite-alunite alteration zone interpreted as a potential feeder to underlying porphyry mineralization at Arena Central backed up by elevated Na-content of alunite, Au, Ag, Cu and most coherently, a Mo in soil anomaly; and,

  2. A separate lithocap to the SE containing a central zone of mineralization with a veinlet visually identified by the field crew as possibly enargite (a copper bearing sulphide mineral found in porphyry lithocaps).

Almadex intends to drill approximately 2,000 metres in these lithocaps in a program planned to start at the end of June, 2024.

Corporate Update

The Company has recently sold a 100% interest in its Willow copper porphyry project to Abacus Mining and Exploration Corp. (“Abacus”). Almadex’s predecessor had previously optioned Willow to Abacus in 2017, in an agreement under which Abacus could acquire a 75% interest in the project. With this recent sale, Almadex will transfer ownership of the Willow concessions to Abacus in exchange for 7,500,000 Abacus shares (the “Initial” shares) and a 2.0% NSR royalty on the Willow project. In addition, on July 31, 2025 Almadex may be issued a certain number of additional Abacus shares to account for any Abacus dilution between now and July 31, 2025.

Upon initial closing of this transaction, Almadex will hold 9,875,000 shares of Abacus as well as a 2% royalty on the Willow project, providing significant ongoing exposure to the discovery potential at Willow.

Finally, further to the Company’s press releases of December 14, 2023 and March 14, 2024, Almadex has taken the decision to submit its claims to arbitration against the United Mexican States (“Mexico”) under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”). This decision comes after a consultation meeting held with Mexican officials on May 30, 2024 that did not result in an amicable resolution of the Company’s investment dispute with Mexico. The Company expects to initiate its claims following expiry of the six-month consultation period required under the CPTPP, which commenced on December 14, 2023.